Regulatory support for ATMP & Biologics developers

Author
Published on
Category
Updates

Developing an ATMP or biologic? Regulatory delays are not an option! Building a biotech pipeline means navigating complex regulatory challenges while keeping development on time and aligned with global expectations.

Starodub BV supports biotech companies developing ATMPs and biologics with fast, focused senior regulatory expertise from day one. From early development strategy through EMA/FDA interactions and execution, we provide clear, practical insight into regulatory readiness, critical gaps and next steps to keep programs moving forward.

Our team provides:

  • Experts in ATMPs, biologics & advanced therapies
  • Experience in health authority interactions for innovative products, including ITF, ODD and PRIME.
  • Regulatory strategy & hands-on RA support
  • Flexible, senior expertise when you need it most

Our support is focused on making the right decisions early. Ready to accelerate your project? Contact us via info@starodub.nl and let’s get started to move your innovation forward and keep your development on track.

Explore Starodub updates

The most expensive regulatory deficiency is the one you discover after submitting your dossier. How much could a regulatory delay cost your development program?

Women’s Health is Finally Moving Towards the Regulatory Attention it Deserves

Your Product Might Be Safe. Is Your IFU?

Jolanda Lamers-Lemmers
Management team member - Senior RA Consultant
Jolanda Lamers-Lemmers

Let's Connect

Talk to an expert